ORG Wealth Partners’s Pulse Biosciences PLSE Stock Holding History

ORG Wealth Partners’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$399	Buy	+8	New	+$337	﹤0.01%	2146

Other funds holding PLSE

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

ORG Wealth Partners's PLSE Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Pulse Biosciences (PLSE) in Q3 2026: 8 shares worth $399. The stake represents ﹤0.01% of the portfolio and ranks #2146 among its holdings.

86 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

ORG Wealth Partners held 8 shares of Pulse Biosciences worth $399 as of Q3 2026.
Pulse Biosciences was a new ORG Wealth Partners position in Q3 2026.
Pulse Biosciences made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2146 holding.
86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.